Studies on the possible mutagenicity of β-adrenergic blocker drugs

This publication has 17 references indexed in Scilit:

• Inhibition of gastrointestinal mucosal glycoprotein synthesis by the β-adrenergic blocking drug, practolol
  Biochemical Pharmacology, 1982
• A carcinogenicity study in mice of a ß-adrenergic antagonist, primidolol; Increased total tumour incidence without tissue specificity
  Toxicology, 1981
• Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species: Role of cytochrome P-450 and P-448
  Xenobiotica, 1981
• Tumorigenicity Assays of Sotalol Hydrochloride in Rats and Mice
  The Journal of Clinical Pharmacology, 1979
• The effects of long-term propranolol on the salivary glands and intestinal serosa of the mouse
  The Journal of Pathology, 1978
• Lack of carcinogenicity of oxprenolol, a β-adrenergic blocking agent
  Toxicology and Applied Pharmacology, 1977
• Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test
  Mutation Research/Environmental Mutagenesis and Related Subjects, 1975
• A rapid in vivo test for chromosomal damage☆
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973
• Carcinogenicity of ‘Alderlin’ (Pronethalol) in Mice*
  Nature, 1965
• Carcinogenic Action of Pronethalol
  BMJ, 1963